These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 3860707)

  • 1. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes.
    Knapp RH; Dewald GW; Pierre RV
    Mayo Clin Proc; 1985 Aug; 60(8):507-16. PubMed ID: 3860707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
    Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
    Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
    Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
    Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis of 54 cases of myelodysplastic syndrome.
    Jotterand-Bellomo M; Parlier V; Schmidt PM; Beris P
    Cancer Genet Cytogenet; 1990 Jun; 46(2):157-72. PubMed ID: 2340487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
    de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
    Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the 5q- deletion: clinical and cytogenetic observations in ten patients and review of the literature.
    Swolin B; Weinfeld A; Ridell B; Waldenström J; Westin J
    Blood; 1981 Nov; 58(5):986-93. PubMed ID: 6945880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic findings in the dysmyelopoietic syndrome.
    Kardon N; Schulman P; Degnan TJ; Budman DR; Davis J; Vinciguerra V
    Cancer; 1982 Dec; 50(12):2834-8. PubMed ID: 6958354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome abnormalities in preleukemic or myelodysplastic syndromes.
    Michels VV; Hoagland HC
    Mayo Clin Proc; 1985 Aug; 60(8):555-6. PubMed ID: 3860708
    [No Abstract]   [Full Text] [Related]  

  • 10. Complex chromosomal abnormalities in a patient with refractory anemia with excess blasts (RAEB).
    Christodoulidou F; Coleman M; Macera MJ; Verma RS
    Cancer Genet Cytogenet; 1991 Jul; 54(2):229-32. PubMed ID: 1884355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic analysis in patients with myelodysplastic syndrome.
    Hu N; Bian M
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The bone marrow karyotype in refractory anemia and preleukemia].
    Bernard P; Vagner-Capodano AM; Stahl A; Broustet A; Boisseau MR; Ayraud N
    Pathol Biol (Paris); 1982 Nov; 30(9):798-801. PubMed ID: 6760084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
    Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
    Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bone marrow karyotype in seventeen cases of refractory anemia with excess of blasts (RAEB).
    Lavezzi AM; Maiolo AT; Chiorboli O; Mozzana R
    Ann Genet; 1983; 26(4):220-4. PubMed ID: 6607702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-cytogenetic correlations in myelodysplasia (preleukemia).
    Pierre RV; Catovsky D; Mufti GJ; Swansbury GJ; Mecucci C; Dewald GW; Ruutu T; Van Den Berghe H; Rowley JD; Mitelman F
    Cancer Genet Cytogenet; 1989 Jul; 40(2):149-61. PubMed ID: 2766240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preleukemias.
    Nowell PC
    Hum Pathol; 1981 Jun; 12(6):522-30. PubMed ID: 7275093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s). A Report from a Reference Centre in Saudi Arabia.
    AlMozain N; Mashi A; Alneami Q; Al-Omran A; Bakshi N; Owaidah T; Khalil S; Khogeer H; Hashmi S; Al-Sweedan S; Morris T; AlNounou R
    Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):39-44. PubMed ID: 33227261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome abnormalities in malignant hematologic disorders.
    Dewald GW; Noel P; Dahl RJ; Spurbeck JL
    Mayo Clin Proc; 1985 Oct; 60(10):675-89. PubMed ID: 3897733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.